Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

127

Full text

108

Free full text

Publication Types

Journal Article

128

Review

Research Support, Non-U.S. Gov't

Clinical Trial, Phase II

Clinical Trial

Multicenter Study

Clinical Trial, Phase I

Randomized Controlled Trial

Comparative Study

Research Support, N.I.H., Extramural

Case Reports

Meta-Analysis

Systematic Review

Observational Study

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase III

Research Support, N.I.H., Intramural

Comment

Letter

Validation Study

Evaluation Study

Network Meta-Analysis

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Carcinoma, Transitional Cell""[mesh_terms]

129 Results

Searching titles within these results

Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A Review.

Areeba Memon, Shahid Ahmed, Angela E Russo

Clinical genitourinary cancer 2024;22(2):434-444

Full Text

Abstract

Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

Anirban P Mitra, Donna E Hansel, Richard J Cote

Seminars in oncology 2012;39(5):524-33

Free Full Text

Abstract

Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Neil Caporaso, Christine M Mueller, Mark H Greene

Urologic oncology 2008;26(5):451-64

Free Full Text

Abstract

A Review of the Latest Evidence on Prognostic Factors in Locally Advanced and Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.

Ion Cojocaru, Mădălin Guliciuc, Elena Cojocaru, Cristina Serban, Grigore Pascaru, Mihnea Bogdan Borz, Vlad Horia Schitcu, Andrei-Ionut Tise, Iulian Osoianu, Laura-Florentina Rebegea

Medicina (Kaunas, Lithuania) 2026;62(1):

Full Text

Abstract

Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma.

Leonidas N Diamantopoulos, Dimitrios Makrakis, Dimitrios Korentzelos, Michail Alevizakos, Jonathan L Wright, Petros Grivas, Vasiliki Bountziouka, Konstantinos Vadikolias, Maria Lambropoulou, Gregory Tripsianis

Urologic oncology 2023;41(6):296.e17-296.e28

Full Text

Abstract

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.

Ernesto Korbenfeld, Yu-Chieh Tsai, Jawaher Ansari, Andrey Soares, Amit Joshi, Alvin Wong, Thomas Powles, Maria T Bourlon, Denis Jardim, Fadi El Karak, Francisco Orlandi, Henry Sze, Jose Zarba, Mubarak Al Mansour, Ray Manneh, Raja Thirumulai, Waleed Al Morsi

Clinical genitourinary cancer 2024;22(2):467-475

Free Full Text

Abstract

Current understanding of the biology of advanced bladder cancer.

Maha Hussain, Sana Al-Sukhun

Cancer 2003;97(8 Suppl):2064-75

Free Full Text

Abstract

MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.

Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, Yang Lu, Qi Wang, Sumankalai Ramachandran, Rebecca Slack Tidwell, Guangchun Han, Xinmiao Yan, Jieru Meng, Ruiping Wang, Anh G Hoang, Wei-Lien Wang, Jian Song, Lidia Lopez, Alex Andreev-Drakhlin, Arlene Siefker-Radtke, Xinqiao Zhang, William F Benedict, Amishi Y Shah, Jennifer Wang, Pavlos Msaouel, Miao Zhang, Charles C Guo, Bogdan Czerniak, Carmen Behrens, Luisa Soto, Vassiliki Papadimitrakopoulou, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jack Lee, Jack Roth, Stephen Swisher, Ignacio Wistuba, John Heymach, Jing Wang, Matthew T Campbell, Eleni Efstathiou, Mark Titus, Christopher J Logothetis, Thai H Ho, Jianjun Zhang, Linghua Wang, Jianjun Gao

Nature communications 2022;13(1):1797

Free Full Text

Abstract

Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature.

Néstor López Guerra, Ana Matas-García, Laura Serra-García, Daniel Morgado-Carrasco, Joan Padrosa, Iban Aldecoa, Yaiza Duque, Maria Casal-Dominguez, Sandra Muñoz-Braceras, Raquel Aranega, Pedro Moreno-Lozano, Judith Cantó-Santos, Glòria Garrabou, Estíbaliz Ruiz-Ortiz, Ernesto Trallero-Araguas, Albert Selva-O'Callaghan, Josep M Grau, Susana Puig, Jiram Torres-Ruiz, Andrew L Mammen, Iago Pinal Fernandez, José C Milisenda

Autoimmunity reviews 2023;22(8):103375

Free Full Text

Abstract

Follow-up Management of Cystectomy Patients.

Madhumitha Reddy, Karim Kader

The Urologic clinics of North America 2018;45(2):241-247

Full Text

Abstract

Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Julieta Afonso, Lúcio L Santos, Adhemar Longatto-Filho, Fátima Baltazar

Nature reviews. Urology 2020;17(2):77-106

Full Text

Abstract

Paclitaxel in the treatment of advanced urothelial cancer.

D F Bajorin

Oncology (Williston Park, N.Y.) 2000;14(1):43-52, 57; discussion 58, 61-2

Full Text

Abstract

Imaging of Upper Tract Urothelial Carcinoma.

Akira Kawashima, Hiroaki Takahashi, Naoki Takahashi, Hirotsugu Nakai, Clinton V Wellnitz, Melissa L Stanton

Radiographics : a review publication of the Radiological Society of North America, Inc 2024;44(11):e240056

Full Text

Abstract

Dual-Energy CT applications in urinary tract cancers: an update.

Eleonora Bicci, Matteo Mastrorosato, Ginevra Danti, Lorenzo Lattavo, Elena Bertelli, Diletta Cozzi, Silvia Pradella, Simone Agostini, Vittorio Miele

Tumori 2023;109(2):148-156

Full Text

Abstract

Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.

Teruki Isobe, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Satoshi Nozaki, Keitaro Iida, Yusuke Noda, Nobuhiko Shimizu, Nami Tomiyama, Rika Banno, Hiroki Kubota, Shuzo Hamamoto, Ryosuke Ando, Noriyasu Kawai, Takahiro Yasui

International journal of clinical oncology 2022;27(1):165-174

Full Text

Abstract

Results: 1 – 15 / 129

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Carcinoma, Transitional Cell""[mesh_terms]

Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A Review.

Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

Familial and genetic risk of transitional cell carcinoma of the urinary tract.

A Review of the Latest Evidence on Prognostic Factors in Locally Advanced and Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.

Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma.

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.

Current understanding of the biology of advanced bladder cancer.

MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.

Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature.

Follow-up Management of Cystectomy Patients.

Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Paclitaxel in the treatment of advanced urothelial cancer.

Imaging of Upper Tract Urothelial Carcinoma.

Dual-Energy CT applications in urinary tract cancers: an update.

Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.

Results for
""Carcinoma, Transitional Cell""[mesh_terms]